At Genmab, we are dedicated to building extra[not]ordinary® futures, together, by developing antibody products and groundbreaking, knock-your-socks-off KYSO antibody medicines® that change lives and the future of cancer treatment and serious diseases. We strive to create, champion and maintain a global workplace where individuals’ unique contributions are valued and drive innovative solutions to meet the needs of our patients, care partners, families and employees.

Our people are compassionate, candid, and purposeful, and our business is innovative and rooted in science. We believe that being proudly authentic and determined to be our best is essential to fulfilling our purpose. Yes, our work is incredibly serious and impactful, but we have big ambitions, bring a ton of care to pursuing them, and have a lot of fun while doing so.

Does this inspire you and feel like a fit? Then we would love to have you join us!

Why Genmab
Our internship program offers hands-on experience with projects that make a real impact on our company’s goals. It’s a fantastic opportunity to learn, grow, and build a strong network while contributing to our bold, extra[not]ordinary® future.

The Role
Are you excited about blending chemical synthesis with cutting-edge cancer therapeutics? Do you want to help design innovative dual-payload ADCs that target tumors in smarter ways? Keep on reading!

Responsibilities
• Assist in developing dual-payload ADCs by designing and synthesizing novel bifunctional linkers.
• Support payload selection to balance the drug-to-antibody ratio for synergistic effects.
• Help conjugate antibodies, screen for efficiency, and evaluate in vitro cytotoxicity.
• Contribute to target validation through testing in relevant tumor models, gaining experience with techniques like HPLC, mass spectrometry, and bioassays.

Requirements
• Currently enrolled in a Master’s degree program at a Dutch university in Molecular Biology, Bioinformatics, Biomedical Sciences, or a related field.
• Interest in chemical synthesis, ADC development, and innovative cancer therapeutics.
• A driven mindset and a passion for learning new techniques in antibody-drug conjugation.

Preferred Qualifications, Capabilities, and Skills
• Any hands-on experience with chemical synthesis, conjugation methods, or ADC characterization will be an advantage.

General Intern Information
• Internship duration: 6-12 months
• Start date: September 1st
• Location: Utrecht, Netherlands
• Hybrid schedule: at least 3 days in the office, 2 days remote per week

What’s Next?

Help us learn about you by submitting a complete and thoughtful application, which includes your resume and motivation letter. These are a way for us to initially get to know you, so it’s important to complete all relevant questions to ensure we have as much information about you as possible. Every application matters to us, and we’ll carefully review each submission as quickly as possible to see if your qualifications align with the role. While we’re unable to provide individual updates, rest assured that we’re working diligently to move through the process efficiently. If you move forward in the process, you’ll receive an email invitation to connect with us and dive deeper into this exciting opportunity. The final stage will bring selected candidates meeting directly with our hiring teams, where you’ll have the chance to showcase your potential. We are committed to keeping you informed and will share decisions with all candidates as soon as we are able. We can't wait to see where this journey takes you! We look forward to receiving your application and exploring the possibility of you joining our team to contribute to the advancement of antibody therapeutics!

About You

• You are genuinely passionate about our purpose

• You bring precision and excellence to all that you do

• You believe in our rooted-in-science approach to problem-solving

• You are a generous collaborator who can work in teams with a broad spectrum of backgrounds

• You take pride in enabling the best work of others on the team

• You can grapple with the unknown and be innovative

• You have experience working in a fast-growing, dynamic company (or a strong desire to)

• You work hard and are not afraid to have a little fun while you do so!

Locations

Genmab maximizes the efficiency of an agile working environment, when possible, for the betterment of employee work-life balance. Our offices are crafted as open, community-based spaces that work to connect employees while being immersed in our powerful laboratories. Whether you’re in one of our office spaces or working remotely, we thrive on connecting with each other to innovate.

About Genmab

Genmab is an international biotechnology company with a core purpose to improve the lives of patients through innovative and differentiated antibody therapeutics. For 25 years, its hard-working, innovative and collaborative team has invented next-generation antibody technology platforms and harnessed translational, quantitative and data sciences, resulting in a proprietary pipeline including bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators and effector function-enhanced antibodies. By 2030, Genmab’s vision is to transform the lives of people with cancer and other serious diseases with Knock-Your-Socks-Off (KYSO®) antibody medicines.

Established in 1999, Genmab is headquartered in Copenhagen, Denmark with international presence across North America, Europe and Asia Pacific. For more information, please visit Genmab.com and follow us on LinkedIn and X.

Genmab is committed to protecting your personal data and privacy. Please see our privacy policy for handling your data in connection with your application on our website Job Applicant Privacy Notice (genmab.com).

Please note that if you are applying for a position in the Netherlands, Genmab’s policy for all permanently budgeted hires in NL is initially to offer a fixed-term employment contract for a year, if the employee performs well and if the business conditions do not change, renewal for an indefinite term may be considered after the contract.